Zuclopenthixol is a typical (first-generation) antipsychotic medication used mainly in the treatment of schizophrenia, psychosis, and severe agitation. It is especially useful for patients who require long-term medication and may struggle with taking oral medications regularly. Zuclopenthixol is available in both oral tablets and long-acting injectable forms, with the injectables commonly used in hospital or community psychiatric settings.
Schizophrenia and Psychotic Disorders
Zuclopenthixol is most commonly prescribed to manage positive symptoms of schizophrenia such as hallucinations, delusions, disorganized thinking, and severe agitation. It helps to stabilize mood, reduce psychotic behavior, and restore functional thinking.
Acute Psychosis and Agitation
In its short-acting injectable form (Zuclopenthixol acetate), it is used in emergency settings for acute psychosis, mania, or severe agitation, particularly when patients are aggressive or at risk of harming themselves or others.
Maintenance Therapy
The long-acting depot injection (Zuclopenthixol decanoate) is ideal for patients with chronic psychotic illnesses who struggle with medication adherence. It is usually administered every 1 to 4 weeks, providing stable drug levels and reducing the risk of relapse.
Zuclopenthixol acts by blocking dopamine D1 and D2 receptors in the brain. By reducing excessive dopamine activity—thought to be a major factor in psychosis—it helps restore emotional and cognitive balance.
Its effects are dose-dependent:
Low doses may have calming effects
Higher doses are more effective in controlling delusions, hallucinations, and thought disturbances
As with other typical antipsychotics, zuclopenthixol can cause neurological and metabolic side effects. Common side effects include:
Extrapyramidal symptoms (EPS): tremors, rigidity, restlessness
Sedation or drowsiness
Dry mouth and blurred vision
Weight gain
Increased saliva production
Menstrual irregularities (due to raised prolactin levels)
Rare but serious side effects:
Tardive dyskinesia: Involuntary facial or limb movements with long-term use
Neuroleptic Malignant Syndrome (NMS): A life-threatening condition marked by high fever, muscle stiffness, and confusion
Cardiac issues: Especially when used with other medications that prolong the QT interval
Elderly with dementia: Zuclopenthixol is not recommended due to an increased risk of stroke and mortality.
Liver function: Should be used cautiously in patients with liver disease.
Alcohol use: Should be avoided, as it may increase sedation and reduce the effectiveness of treatment.
Driving and machinery: Caution is advised, especially during the first days of treatment due to potential drowsiness or impaired alertness.
Nature Consultancy Limited is regulated by CQC to provide care at Emotions Clinic
Phone : +44(0)1782 768656
Email : admin@emotions-clinic.co.uk
Lumbung Hidup St 425 East Java Madiun City Block ABC 123
Monday - Friday 08 AM - 10 PM